Cargando…
A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer’s disease and tauopathy in mice
Accumulation of tau protein is a key pathology of age-related neurodegenerative diseases such as Alzheimer's disease and progressive supranuclear palsy. Those diseases are collectively termed tauopathies. Tau pathology is associated with axonal degeneration because tau binds to microtubules (MT...
Autores principales: | Onishi, Tomohiro, Maeda, Ryouta, Terada, Michiko, Sato, Sho, Fujii, Takahiro, Ito, Masahiro, Hashikami, Kentaro, Kawamoto, Tomohiro, Tanaka, Maiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322070/ https://www.ncbi.nlm.nih.gov/pubmed/34326423 http://dx.doi.org/10.1038/s41598-021-94923-w |
Ejemplares similares
-
A new brain‐penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease
por: Fujii, Takahiro, et al.
Publicado: (2021) -
518 Prescribing practices of atypical antipsychotics in the burn ICU
por: Gayed, Rita, et al.
Publicado: (2022) -
PM518. Medication Adherence in schizophrenia: Focus on therapeutic relationship
por: Chang, Jhin-Goo, et al.
Publicado: (2016) -
MON-518 Osteoporosis in a Young Adult with Trisomy 13
por: Wynn, Anne, et al.
Publicado: (2019) -
THU518 Ectopic Cushing Syndrome In A Case Of Ewing Sarcoma
por: Fasen, Madeline, et al.
Publicado: (2023)